Compare
Up to four compounds, side by side.
Search or pick a starting set. Differences light up so you can spot them fast.
Lixisenatide
1 / 4
Peptide
GLP-1 Agonist
LixisenatideOverview
Summary
Short-acting prandial GLP-1, mostly clinically displaced now.
Category
GLP-1 Agonist
Mechanism
Short-acting prandial GLP-1, mostly clinically displaced now.
Effects
Top outcomes
- Fat loss70
Evidence
Established
Practical
Half-life
Short (~hours)
Administration
subq
Risk
Legal status
approved some regions
Safety
Educational reference only. Long-term human safety varies; consult a peptide-literate clinician.
Try a preset